Wu Tsai Neurosciences Institute


Showing 21-30 of 41 Results

  • Garry Gold

    Garry Gold

    Stanford Medicine Professor of Radiology and Biomedical Imaging
    On Partial Leave from 2026-08-02 To 2027-02-15

    Current Research and Scholarly InterestsMy primary focus is application of new MR imaging technology to musculoskeletal problems. Current projects include: Rapid MRI for Osteoarthritis, Weight-bearing cartilage imaging with MRI, and MRI-based models of muscle. We are studying the application of new MR imaging techniques such as rapid imaging, real-time imaging, and short echo time imaging to learn more about biomechanics and pathology of bones and joints. I am also interested in functional imaging approaches using PET-MRI.

  • Jeffrey Goldberg, MD, PhD

    Jeffrey Goldberg, MD, PhD

    Blumenkranz Smead Professor

    Current Research and Scholarly InterestsLab research on molecular mechanisms of survival and regeneration in the visual system; retinal development and stem cell biology; nanoparticles and tissue engineering. Clinical trials in imaging, biomarker development, and neuroprotection and vision restoration in glaucoma and other neurodegenerative diseases.

  • Andrea Goldsmith

    Andrea Goldsmith

    Stephen Harris Professor in the School of Engineering, Emerita

    BioAndrea Goldsmith is the Dean of Engineering and Applied Science and the Arthur LeGrand Doty Professor of Electrical and Computer Engineering at Princeton University. She was previously the Stephen Harris Professor of Engineering and Professor of Electrical Engineering at Stanford University, where she is now Harris Professor Emerita. Her research interests are in information theory, communication theory, and signal processing, and their application to wireless communications, interconnected systems, and biomedical devices. She founded and served as Chief Technical Officer of Plume WiFi (formerly Accelera, Inc.) and of Quantenna (QTNA), Inc, and she serves on the Board of Directors for Intel (INTC), Medtronic (MDT), Crown Castle Inc (CCI), and the Marconi Society. She also serves on the Presidential Council of Advisors on Science and Technology (PCAST). Dr. Goldsmith is a member of the National Academy of Engineering, the Royal Academy of Engineering, and the American Academy of Arts and Sciences. She is a Fellow of the IEEE and has received several awards for her work, including the Marconi Prize, the ACM Sigmobile Outstanding Contribution Award, the IEEE Sumner Technical Field Award, the ACM Athena Lecturer Award, the ComSoc Armstrong Technical Achievement Award, the Kirchmayer Graduate Teaching Award, the WICE Mentoring Award, and the Silicon Valley/San Jose Business Journal’s Women of Influence Award. She is author of the book ``Wireless Communications'' and co-author of the books ``MIMO Wireless Communications,” “Principles of Cognitive Radio,” and “Machine Learning and Wireless Communications,” all published by Cambridge University Press, as well as an inventor on 29 patents. She received the B.S., M.S. and Ph.D. degrees in Electrical Engineering from U.C. Berkeley.

    Dr. Goldsmith is the founding Chair of the IEEE Board of Directors Committee on Diversity and Inclusion. She served as President of the IEEE Information Theory Society in 2009, as founding Chair of its Student Committee, and as founding Editor-in-Chief of the IEEE Journal on Selected Areas in Information Theory. She has also served on the Board of Governors for both the IEEE Information Theory and Communications Societies. At Stanford she served as Chair of Stanford’s Faculty Senate and for multiple terms as a Senator, and on its Academic Council Advisory Board, Budget Group, Committee on Research, Planning and Policy Board, Commissions on Graduate and on Undergraduate Education, Faculty Women’s Forum Steering Committee, and Task Force on Women and Leadership.

  • Andrea Goldstein-Piekarski

    Andrea Goldstein-Piekarski

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)

    BioDr. Goldstein-Piekarski directs the Computational Psychiatry, Neuroscience, and Sleep Laboratory (CoPsyN Sleep Lab) as an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and PI within the Sierra-Pacific Mental Illness Research, Education and Clinical Center (MIRECC) at the Palo Alto VA. She received her PhD in 2014 at the University of California, Berkeley where she studied the consequences of sleep on emotional brain function. She then completed a Postdoctoral fellowship at Stanford focusing on understanding the brain basis of anxiety and depression.

    As the director of the CoPsyN Sleep Lab she is developing a translational, interdisciplinary research program that combines human neuroimaging, high-density EEG sleep recording, and computational modeling to understand the neural mechanisms through which sleep disruption contributes to affective disorders, particularly depression, across the lifespan. The ultimate goals of this research are to (1) develop mechanistically-informed interventions that directly target aspects of sleep and brain function to prevent and treat affective disorders and (2) identify novel biomarkers which can identify which individuals are most likely to experience improved mood following targeted sleep interventions.

    This work is currently supported by The KLS Foundation, a R01 from National Institute of Mental Health, and a R61 from the National Institute of Mental Health.

  • Natalia Gomez-Ospina

    Natalia Gomez-Ospina

    Assistant Professor of Pediatrics (Genetics)

    Current Research and Scholarly Interests1. Genome Editing and HSPC-Based Therapeutics

    Dr. Gomez-Ospina’s research focuses on developing autologous hematopoietic stem and progenitor cell therapies using CRISPR/Cas9-mediated genome editing. Her work includes targeted integration of therapeutic transgenes into genomic safe-harbor loci, optimization of editing efficiency and safety, and development of transplantation and conditioning strategies that preserve long-term engraftment. A major goal is to create reusable, mutation-agnostic therapeutic platforms that can be adapted across diseases. Her translational work also extends to GMP manufacturing, analytical development, and IND-enabling studies needed to move genome-edited HSPC products toward clinical trials.

    2. Neurometabolic and Neurodegenerative Disease Therapeutics

    A major area of interest is the development of definitive therapies for lysosomal storage disorders and other neurogenetic diseases, including MPS I, Gaucher disease, Krabbe disease, progranulin deficiency, and Friedreich’s ataxia. Her laboratory investigates how hematopoietic-derived cells can deliver therapeutic proteins to peripheral tissues and the central nervous system. This includes strategies to enhance microglial replacement, improve CNS engraftment, and harness myeloid cells as therapeutic vehicles. The broader objective is to establish cell-based approaches capable of treating both inherited neurometabolic disorders and more common neurodegenerative diseases.

    3. Rare Disease Genetics, Functional Genomics, and Lysosome Biology

    Dr. Gomez-Ospina also studies the molecular basis of rare and undiagnosed genetic disorders. Through clinical genetics, international collaborations, and the NIH Undiagnosed Diseases Network, her work contributes to novel disease-gene discovery, functional validation of candidate variants, and definition of genotype–phenotype relationships. Her laboratory also investigates lysosomal biology and develops systems-level approaches, including the Lysosome Disease Atlas, to connect lysosome-associated genes with cellular function and human phenotypes. These efforts aim to improve diagnosis while identifying new disease mechanisms and therapeutic opportunities.

    For more information go to our website:

    https://www.gomezospina.com/

  • Miriam B. Goodman

    Miriam B. Goodman

    Mrs. George A. Winzer Professor of Cell Biology
    On Partial Leave from 2026-09-01 To 2027-08-31

    Current Research and Scholarly InterestsWe study the molecular events that give rise to the sensation of touch and chemical stressors that compromise touch sensation in C. elegans. To do this, we use a combination of quantitative behavioral analysis, genetics, in vivo electrophysiology, and heterologous expression of ion channels. We collaborate with physicists and other physiologist to expand our experimental research.

  • Deborah M Gordon

    Deborah M Gordon

    Paul S. and Billie Achilles Professor of Environmental Biology

    Current Research and Scholarly InterestsProfessor Deborah M Gordon studies the evolutionary ecology of collective behavior. Ant colonies operate without central control, using local interactions to regulate colony behavior.

  • Ian Gotlib

    Ian Gotlib

    Marjorie Mhoon Fair Professor

    Current Research and Scholarly InterestsCurrent interests include social, cognitive, and biological factors in affective disorders; neural and cognitive processing of emotional stimuli and reward by depressed persons; behavioral activation and anhedonia in depression; social, emotional, and biological risk factors for depression in children.